Page last updated: 2024-10-27

fluconazole and Transposition of Great Vessels

fluconazole has been researched along with Transposition of Great Vessels in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Transposition of Great Vessels: A congenital cardiovascular malformation in which the AORTA arises entirely from the RIGHT VENTRICLE, and the PULMONARY ARTERY arises from the LEFT VENTRICLE. Consequently, the pulmonary and the systemic circulations are parallel and not sequential, so that the venous return from the peripheral circulation is re-circulated by the right ventricle via aorta to the systemic circulation without being oxygenated in the lungs. This is a potentially lethal form of heart disease in newborns and infants.

Research Excerpts

ExcerptRelevanceReference
" The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis."3.73Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Minette, MS1
Ibsen, LM1

Other Studies

1 other study available for fluconazole and Transposition of Great Vessels

ArticleYear
Survival of candida sepsis in extracorporeal membrane oxygenation.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2005, Volume: 6, Issue:6

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb

2005